Sentinel Lymph Node Techniques in Urologic Oncology: Current Knowledge and Application

Area of Science:

• Urologic Oncology
• Surgical Oncology
• Diagnostic Imaging

Background:

• Lymph node (LN) metastases significantly worsen prognosis in urological cancers.
• Current imaging lacks sensitivity for micrometastases, necessitating broad lymph node dissection (LND).
• Existing LND templates are suboptimal, risking under- or over-staging.

Purpose of the Study:

• To review the current knowledge and future potential of sentinel lymph node (SLN) biopsy in urological malignancies.
• To discuss the challenges and advancements in SLN techniques for prostate, bladder, and kidney cancers.

Main Methods:

• Review of existing literature on SLN biopsy in urologic oncology.
• Analysis of current limitations and potential improvements in tracers, imaging, and surgical approaches.

Main Results:

• SLN biopsy is established in other cancers but remains experimental in urologic oncology.
• High false-negative rates and limited data hinder its widespread adoption in prostate, bladder, and kidney cancers.
• Advancements in technology may enhance SLN procedure efficacy.

Conclusions:

• Sentinel lymph node biopsy holds potential for accurate staging in urological malignancies.
• Further research and technological development are crucial for optimizing SLN techniques in urologic oncology.